Mounjaro Cost: With Insurance, Without, and the Savings Card

Mounjaro pricing is confusing for one specific reason: the number you pay depends less on the drug than on which of four buckets you fall into. Commercially insured with coverage, commercially insured without coverage, government insured, or uninsured — those four paths land at wildly different prices, and only two of them can use the manufacturer card at all. Below is what each one costs according to Lilly's published terms, with nothing rounded, inferred, or wished into existence.

Mounjaro's List Price and What Actually Sets Your Cost

Lilly publishes Mounjaro's wholesale acquisition cost (WAC) in the state pricing disclosure sheets it is required to file. Those sheets list $1,079.77 for a pack of four single-dose pens — a 28-day supply — and they list that identical figure for all six strengths: 2.5, 5, 7.5, 10, 12.5, and 15 mg per 0.5 mL.

That flat structure is worth understanding, because it is the opposite of how most people assume drug pricing works. Titrating from a starting dose up to a higher maintenance dose does not raise Mounjaro's list price. One 28-day supply costs the same at 15 mg as it does at 2.5 mg.

So the real question is never "what does Mounjaro cost." It is which bucket are you in. Here is the whole map on one line each:

The Mounjaro Savings Card: The Published Terms, Tier by Tier

The Mounjaro Savings Card is Lilly's copay-assistance program. It has two tiers, and which one you land in depends entirely on whether your commercial plan covers Mounjaro. Both tiers apply only to the single-dose pen NDCs listed in the terms; the terms state that other methods of administration are not eligible for program savings.

Eligibility, as the terms state it

To use the card, Lilly's terms require that you attest to all of the following:

• You have been prescribed the Mounjaro single-dose pen for an approved use consistent with FDA-approved product labeling.
• You are enrolled in a commercial drug insurance plan.
• You are not enrolled in any state, federal, or government-funded healthcare program — the terms name Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE/CHAMPUS, and any state prescription drug assistance program.
• You are a resident of the United States or Puerto Rico.
• You are 18 years of age or older.

Two additional state-level carve-outs appear in the terms: savings are not valid for Massachusetts residents if an AB-rated generic equivalent is available, or for California residents if an FDA-approved therapeutic equivalent is available. Participation also requires a valid patient HIPAA authorization, and Lilly reserves the right to terminate, rescind, revoke, or amend eligibility criteria and terms at any time.

"Mounjaro Coupon" vs the Manufacturer Savings Card

"Mounjaro coupon," "Mounjaro manufacturer coupon," and "Mounjaro coupon card" are all searches for the same thing, and the answer is the same in every case: the manufacturer program is the Mounjaro Savings Card. There is no separate Lilly coupon sitting alongside it, and no code that unlocks a lower price for people the card excludes.

This matters because "coupon" sets the wrong expectation. A grocery coupon works for anyone holding it. A manufacturer copay card is a different instrument: it is designed to reduce cost-sharing for people who already have commercial insurance, which is precisely why government-insured patients are excluded — federal anti-kickback rules bar manufacturer copay assistance for beneficiaries of federal healthcare programs. That exclusion is not an oversight in the terms; it is the reason the terms exist in that shape.

If You Want This for Weight Loss, Read This First

This is the most important section on the page, because a large share of people searching for a Mounjaro coupon are not managing type 2 diabetes. They want the weight-loss effect tirzepatide is known for. The honest answer changes what you should be pricing.

Mounjaro is FDA-approved for type 2 diabetes. The prescribing information describes it as a GIP and GLP-1 receptor agonist "indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus." Lilly's own consumer site puts the corollary in five words: "Mounjaro is not a weight loss drug." Prescribing it for weight loss is off-label.

There is a same-molecule product built for this purpose. Zepbound is the FDA-approved tirzepatide brand for chronic weight management — same active ingredient, different indication, different label, its own manufacturer savings program, and its own self-pay pricing. If weight management is the goal, that is the product to price and the conversation to have with a licensed clinician. See our Zepbound cost guide for that side of the ledger.

For background on how the two tirzepatide brands and the semaglutide brands differ, our semaglutide vs tirzepatide comparison maps the molecules to their indications, and the tirzepatide dosing guide covers what the FDA labels specify for each. None of that is a substitute for a prescriber's judgment about which product, if any, fits your situation.

Insurance Coverage: On-Label vs Off-Label

Coverage is decided by your insurer, not by the manufacturer, and it varies plan to plan. But the general pattern is consistent enough to plan around.

• Prescribed for type 2 diabetes. This is the indication the drug is approved for, and many commercial plans cover it — frequently behind a prior authorization that asks the prescriber to document the diagnosis, and sometimes behind step therapy requiring you to try another agent first.
• Prescribed off-label for weight loss. Much less predictable. Many plans exclude weight-management drugs entirely as a benefit category, and an off-label request for a diabetes drug is a common denial. Some plans cover weight-management medications, but if so they will generally want the drug that is actually approved for it.
• Medicare and Medicaid. Coverage rules differ by plan and by state, and these are exactly the beneficiaries the savings card excludes. If you are in this group, your plan's cost-sharing is your price; the manufacturer card is not available to lower it.

The single most useful thing you can do before you fill is call the number on your insurance card and ask three questions: is Mounjaro on the formulary, what tier is it on, and does it require prior authorization. That call tells you which savings-card tier you are in, which is the number that actually decides your cost.

What Mounjaro Costs Without Insurance

If you have no drug insurance, the savings card is not available to you — its terms require enrollment in a commercial drug insurance plan. Lilly's direct-to-patient channel is the published alternative.

LillyDirect lists Mounjaro for self-pay at a price starting at $499 per month for the single-dose prefilled pen, and lists that same starting price at every strength from 2.5 mg through 15 mg. Against a $1,079.77 list price for the same 28-day supply, that is the difference between the sticker and the direct channel — and it is the same $499 floor the savings card offers commercially insured patients whose plans do not cover the drug.

Cheaper Routes to Tirzepatide

Brand Mounjaro through a pharmacy is one of several ways people access tirzepatide, and it is usually not the cheapest. The trade-offs are real in both directions, so price the alternatives with your eyes open:

• Clinic programs that bundle the medication. Cash-pay weight-loss clinics often quote a single monthly fee covering the drug, prescriber visits, and titration. Our tirzepatide cost guide carries verified per-clinic monthly prices pulled from clinic websites and dated, with membership-only prices tagged separately so a membership fee is never mistaken for an all-in price.
• Cross-drug price comparison. If you are flexible on molecule, our cheapest GLP-1 without insurance guide compares the self-pay routes across the class rather than within one brand.
• Know the full brand map first. The complete GLP-1 medications list maps every approved GLP-1 and dual GIP/GLP-1 product to its generic name and its FDA-approved indication — the fastest way to see which brand matches your actual goal.
• Compare local clinics. Browse cash-pay options by state in the GLP-1 and weight-loss clinic directory, or see how this sits against other cash-pay services in our price index.

One caution worth stating plainly: a lower monthly number is not automatically the better deal. What the price includes — the medication itself, prescriber visits, lab work, titration support — varies enormously between programs, and a low membership fee that bills the drug separately can cost more all-in than a mid-priced bundled program.

Things to Know Before You Fill

• Mounjaro is a prescription medication. It requires a licensed prescriber, and the FDA label carries a boxed warning about the risk of thyroid C-cell tumors, with contraindications including a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
• The savings card covers pens only. The terms list specific single-dose pen NDCs and state that other methods of administration are not eligible for program savings.
• Eligibility is checked at every fill. Meeting the criteria once does not lock in the price; a change in your insurance can end eligibility mid-year.
• Savings caps can bind before the year ends. With a $1,950 annual cap on the covered tier and $8,411 on the uncovered tier, it is worth knowing where you stand against the cap rather than being surprised at a later fill.
• Do not stack discounts. The terms prohibit combining card savings with any other coupon, discount card, or cash discount card for Mounjaro.
• Prices and terms change. List prices, self-pay prices, and savings-card terms are all revised periodically. Verify the current figures with Lilly and your pharmacy before you rely on them.

Related guides

• Same molecule, weight-management brand: Zepbound cost guide
• Clinic program pricing: verified monthly tirzepatide program prices
• Brand comparison: Mounjaro vs Ozempic
• What the labels specify: tirzepatide dosing guide